| Mobile Web

Search results for prompt

AI & Enterprise

Checkpoint Korea says AI security-first gains are taking shape, aims to expand firewall market share

Lim Hyun-ho (임현호), who took charge of Checkpoint Korea last November, said he aims to take an edge in AI security and use it to expand market share in firewalls. He said the company is seeing results and received high marks from customers during a proof-of-concept project last quarter. Checkpoint is focusing on its AI Defense Plane platform and AI-based CTEM solutions, while stepping up efforts to target the financial sector and invest in compliance infrastructure in Korea.

AI & Enterprise

Genon launches GenGuard AI security solution with natural-language policy setting

Genon, a generative AI solutions company, said on Oct. 26 it has launched GenGuard, an enterprise AI security solution. The product judges and blocks requests sent to AI services and generated responses based on security policies set by companies, and can be used regardless of whether GenOS is adopted. GenGuard supports natural-language policy settings and privacy protection, and the company also disclosed a lightweight guardrail model and a Korean policy evaluation dataset.

Industry

Moderna, Merck personalised mRNA cancer vaccine cuts melanoma recurrence or death risk by 42%

A personalised mRNA cancer vaccine being co-developed by Moderna and Merck reduced the risk of recurrence or death in melanoma patients by 42%, the report said. In a phase 3 trial involving 1,137 patients who had tumours removed by surgery, those receiving the vaccine intismeran with Merck\'s Keytruda outperformed a Keytruda-plus-placebo group. The companies are discussing approval procedures with regulators, with detailed results due at a European oncology meeting in Madrid.